К основному контенту

Azilect

Azilect

     * Generic Name: rasagiline
     * Brand Name: Azilect


     * What is rasagiline (Azilect)?
     * What are the possible side effects of rasagiline (Azilect)?
     * What is the most important information I should know about
       rasagiline (Azilect)?
     * What should I discuss with my healthcare provider before taking
       rasagiline (Azilect)?
     * How should I take rasagiline (Azilect)?
     * What happens if I miss a dose (Azilect)?
     * What happens if I overdose (Azilect)?
     * What should I avoid while taking rasagiline (Azilect)?
     * What other drugs will affect rasagiline (Azilect)?
     * Where can I get more information (Azilect)?

What is rasagiline (Azilect)?

   Rasagiline works by increasing the levels of certain chemicals in the
   brain.

   Rasagiline is used to treat symptoms of Parkinson's disease
   (stiffness, tremors, spasms, poor muscle control). Rasagiline is
   sometimes used with another medicine called levodopa.

   Rasagiline may also be used for purposes not listed in this medication
   guide.

What are the possible side effects of rasagiline (Azilect)?

   Get emergency medical help if you have signs of an allergic reaction:
   hives; difficult breathing; swelling of your face, lips, tongue, or
   throat.

   Call your doctor at once if you have:
     * extreme drowsiness or falling asleep suddenly, even after feeling
       alert;
     * unusual changes in mood or behavior;
     * a light-headed feeling, like you might pass out;
     * worsening symptoms of Parkinson's disease (especially uncontrolled
       muscle movements); or
     * dangerously high blood pressure--severe headache, blurred vision,
       pounding in your neck or ears, anxiety, confusion, severe chest
       pain, shortness of breath, severe weakness, seizure.

   Seek medical attention right away if you have symptoms of serotonin
   syndrome, such as: agitation, hallucinations, fever, sweating,
   shivering, fast heart rate, muscle stiffness, twitching, loss of
   coordination, nausea, vomiting, or diarrhea.

   Some people taking rasagiline with levodopa have fallen asleep during
   normal daytime activities such as working, talking, eating, or driving.
   Tell your doctor if you have any problems with daytime sleepiness or
   drowsiness.

   You may have increased sexual urges, unusual urges to gamble, or other
   intense urges while taking this medicine. Talk with your doctor if this
   occurs.

   Common side effects may include:
     * dizziness, drowsiness;
     * sleep problems (insomnia), strange dreams;
     * involuntary muscle movements;
     * loss of appetite, weight loss;
     * indigestion, stomach pain, nausea, vomiting, constipation;
     * joint pain or stiffness;
     * swelling in your hands or feet;
     * dry mouth, cough; or
     * flu symptoms (fever, chills, body aches).

   This is not a complete list of side effects and others may occur. Call
   your doctor for medical advice about side effects. You may report side
   effects to FDA at 1-800-FDA-1088.

What is the most important information I should know about rasagiline
(Azilect)?

   Tell your doctor about all medicines you have used in the 2-week period
   before you start taking rasagiline. Many drugs can interact with
   rasagiline, and some drugs should not be used together.

   Do not rasagiline if you have used an MAO inhibitor in the past 14
   days, such as isocarboxazid, linezolid, methylene blue
   injection, phenelzine, selegiline, or tranylcypromine.

   Azilect Patient Information including How Should I Take
   Parkinson's Disease:Symptoms, Stages and Treatment

   Parkinson's Disease Slideshow Pictures
   Dementia, Alzheimer's, and Aging Brains

   Dementia Slideshow Pictures
   RxList

   Take the Parkinson's Quiz

What should I discuss with my healthcare provider before taking rasagiline
(Azilect)?

   You should not take rasagiline if you are allergic to it.

   Do not use rasagiline if you have used any other MAO inhibitor in the
   past 14 days. A dangerous drug interaction could occur. MAO inhibitors
   include isocarboxazid, linezolid, methylene blue injection, phenelzine,
   selegiline, tranylcypromine, and others.

   Many medicines can interact with rasagiline and cause unwanted or
   dangerous effects. Your doctor may need to change your treatment plan
   if you use any of the following drugs:
     * cyclobenzaprine (a muscle relaxer);
     * dextromethorphan (contained in many over-the-counter cough
       medicines);
     * meperidine (Demerol);
     * methadone;
     * St. John's wort; or
     * tramadol (Ultram, Ultracet).

   Some medicines can interact with rasagiline and cause a serious
   condition called serotonin syndrome. Be sure your doctor knows if you
   also take stimulant medicine, opioid medicine, herbal products, or
   medicine for depression, mental illness, Parkinson's disease,
   migraine headaches, serious infections, or prevention of nausea
   and vomiting. Ask your doctor before making any changes in how or when
   you take your medications.

   To make sure rasagiline is safe for you, tell your doctor if you have
   ever had:
     * high or low blood pressure;
     * liver or kidney disease; or
     * if you take ciprofloxacin (an antibiotic).

   People with Parkinson's disease may have a higher risk of skin
   cancer (melanoma). Talk to your doctor about this risk and what
   skin symptoms to watch for.

   It is not known whether this medicine will harm an unborn baby. Tell
   your doctor if you are pregnant or plan to become pregnant.

   It is not known whether rasagiline passes into breast milk or if it
   could harm a nursing baby. Tell your doctor if you are breast-feeding a
   baby.

How should I take rasagiline (Azilect)?

   Follow all directions on your prescription label. Your doctor may
   occasionally change your dose. Do not take this medicine in larger or
   smaller amounts or for longer than recommended.

   If you take rasagiline alone, your dose may be different than if you
   take rasagiline with other Parkinson's medications. Follow your
   doctor's dosing instructions very carefully.

   Rasagiline may be only part of a complete program of treatment that
   also includes a special diet. Follow the diet plan created for you
   by your doctor or nutrition counselor.

   Get familiar with the list of foods you should avoid to help prevent
   certain side effects of rasagiline.

   Call your doctor if your Parkinson's symptoms do not improve, or if
   they get worse while using rasagiline.

   Do not stop using rasagiline suddenly, or you could have unpleasant
   withdrawal symptoms. Ask your doctor how to safely stop using
   rasagiline.

   Store at room temperature away from moisture and heat.

   Azilect Patient Information including If I Miss a Dose
   Parkinson's Disease:Symptoms, Stages and Treatment

   Parkinson's Disease Slideshow Pictures
   Dementia, Alzheimer's, and Aging Brains

   Dementia Slideshow Pictures
   RxList

   Take the Parkinson's Quiz

What happens if I miss a dose (Azilect)?

   Take the missed dose as soon as you remember. Skip the missed dose if
   it is almost time for your next scheduled dose. Do not take extra
   medicine to make up the missed dose.

What happens if I overdose (Azilect)?

   Seek emergency medical attention or call the Poison Help line at
   1-800-222-1222.

   Overdose symptoms may include drowsiness, dizziness, severe headache,
   hallucinations, feeling agitated or irritable, muscle spasms in
   your neck or jaw, sweating, cold or clammy skin, shallow breathing,
   fainting, or seizure (convulsions).

What should I avoid while taking rasagiline (Azilect)?

   Rasagiline may impair your thinking or reactions. Avoid driving or
   operating machinery until you know how this medicine will affect you.
   Avoid getting up too fast from a sitting or lying position, or you may
   feel dizzy. Get up slowly and steady yourself to prevent a fall.

   Drinking alcohol can increase certain side effects of rasagiline.
   Especially avoid red wine, vermouth, and tap beers or ale.

   Also avoid eating foods that are high in tyramine, such as aged
   cheeses, fava beans, soy sauce, herring, pickled or processed meats
   and fish, and meats that are aged, dried, smoked, or fermented. Eating
   tyramine while you are taking rasagiline can raise your blood pressure
   to dangerous levels which could cause life-threatening side effects.

What other drugs will affect rasagiline (Azilect)?

   Taking rasagiline with other drugs that make you sleepy can worsen this
   effect. Ask your doctor before taking a sleeping pill, narcotic
   medication, muscle relaxer, or medicine for anxiety, depression, or
   seizures. Tell your doctor if you have taken an antidepressant during
   the 2-week period before you start taking rasagiline.

   Many drugs can interact with rasagiline, and some drugs should not be
   used together. This includes prescription and over-the-counter
   medicines, vitamins, and herbal products. Not all possible interactions
   are listed in this medication guide. Tell your doctor about all your
   current medicines and any medicine you start or stop using.

Where can I get more information (Azilect)?

   Your doctor or pharmacist has more information about rasagiline.
     __________________________________________________________________


Комментарии

Популярные сообщения из этого блога

A healthy diet may trigger a better response to a certain kind of melanoma treatment. How?

New research suggests that a diet that's full of fiber appears to lead to more diverse intestinal bacteria (microbiome). In turn, a thriving gut microbiome is linked to a stronger response to an immune therapy for the aggressive skin cancer. "We found that patients eating a high-fiber diet at the start of therapy were about five times more likely to respond to the anti-PD-1 immunotherapy," said study author Christine Spencer. She's a research scientist with the Parker Institute for Cancer Immunotherapy in San Francisco. Anti-PD-1 immunotherapy helps the immune system recognize cancer cells as dangerous cells that need to be destroyed, according to the American Cancer Society (ACS). The cancer drugs Keytruda and Opdivo are examples of this type of immunotherapy. Melanoma is a type of skin cancer. It only accounts for about 1 percent of all skin cancers, but is responsible for most skin cancer deaths, the ACS says. Several recent studies have suggested that a ...

American Heart Association News

On Feb. 1, 1961, twins Debbie and Donna Horst arrived at the White House to fanfare. The 6-year-olds, decked out in fancy dresses and satin sashes, found themselves surrounded by a pressing crowd and a sea of blinding flashbulbs as they made their way to see Jacqueline Kennedy. The girls -- both born with holes in their aortas -- were meeting with the first lady to kick off a national campaign to raise awareness about congenital heart defects. "There were hundreds of reporters because this was Jacqueline Kennedy' first public act as first lady," Debbie said. She recalls being startled when the reporters asked Mrs. Kennedy if they could move in closer. "It was frightening because they all jumped at us at once." The Pennsylvania twins, just a few weeks from turning 7, were among the first "Heart Fund Sweethearts" in the campaign to raise money as well as awareness. The month before, they'd met up with Micki and Patricia Gane, also of Pennsylvania...

Agile Therapeutics Resubmits New Drug Application (NDA) for its Transdermal Low-Dose

Agile Therapeutics Resubmits New Drug Application (NDA) for its Transdermal Low-Dose Contraceptive Patch, Twirla PRINCETON, N.J., May 17, 2019 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today announced it has resubmitted to the U.S. Food and Drug Administration (FDA) the NDA for its lead product candidate, Twirla®, an investigational low-dose combined hormonal contraceptive patch (AG200-15).  Agile resubmitted the NDA in response to a December 2017 Complete Response Letter (CRL) from the FDA, which identified deficiencies relating to (i) quality control adhesion test methods for the Twirla manufacturing process, (ii) observations identified during an inspection of a facility of our third-party manufacturer for the Twirla NDA that must be resolved, and (iii) questions on the in vivo adhesion properties of Twirla and their potential relationship to the SECURE clinical trial results. The resubmitted NDA includes the results from a...